Epidemiological characteristics of platelet aggregability

British Medical Journal (Clinical research ed.)

Volumn 290, Issue 6466, 1985, Pages 428-432

  Meade, T W ^a   Vickers, M V ^a   Thompson, S G ^a   Stirling, Y ^a   Haines, A P ^a   Miller, G J ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; FIBRINOGEN;

BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; EPIDEMIOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOKING; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; ALCOHOL DRINKING; CORONARY DISEASE; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; SMOKING;

EID: 0021821558     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.290.6466.428     Document Type: Article

References (36)

1. Bom GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67-68.
2. Bom GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-9.
3. Meade TW, North WRS, Chakrabarti R, Haines AP, Stirling Y. Population- based distributions of haemostatic variables. Br Med Bull 1977;33:283-8.
4. Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980;1: 1050-4.
5. Meade TW, Brozovic M, Chakrabarti R, Howarth DJ, North WRS, Stirling Y. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol 1976;34:353.
6. Slack J, Noble N, Meade TW, North WRS. Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br Med J 1977;2:353-6.
7. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979;1: 153-6.
8. Thompson SG, Vickers MV. Methods in dose response platelet aggregometry. Thromb Haemost (in press).
9. Dixon WJ, Jennrich R. 2R stepwise regression. In: Dixon WJ, ed. BMDP Statistical Software. Los Angeles: University of California Press, 1981:251-64.
10. Frane J. 9R. All possible subsets regression. In: Dixon WJ, ed. BMDP Statistical Software. Los Angeles: University of California Press, 1981:264-77.
11. Thompson SG. A method of analysis of laboratory data in an epidemiological study where time-trends are present. Statistics in Medicine 1983;2:147-53.
12. Zawilska KM, Born GVR, Begent NA. Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits. Br J Haematol 1982;50:317-25.
13. Saniabadi AR, Lowe GDO, Barbenel JC, Forbes CD. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: Additional evidence for the role of ADP. Thromb Haemost 1984;1:115-8.
14. Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature 1975;253:355-7.
15. Coppe D, Wessinger SJ, Ransil BJ, Harris W, Salzman E. Sex differences in the platelet response to aspirin. Thromb Res 1981;23:1-21.
16. Nenci GG, Agnelli G, Parise P, Merante F, Ballatori E. Sex difference in circulating platelet aggregates and response to antiplatelet treatment. Thromb Haemost 1982:48:341
17. Harris WH, Salzman EW, Athanasoulis CA, Waitman AC, Desanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 1977;297:1246-9.
18. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978;299:53-9.
19. Hawkins RI. Smoking, platelets and thrombosis. Nature 1972;236:450-2.
20. Levine PH. Smoking and platelet function. Circulation 1973;48:619-23.
21. Belch JJF, McArdle BM, Burns P, Lowe GDO, Forbes CD. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost 1984;51:6-8.
22. Haut MJ, Cowan DH. The effect of ethanol on hemostatic properties of human blood platelets. Am J Med 1974;56:22.
23. Fenn CG, Littleton JM. Interactions between ethanol and dietary fat in determining human platelet function. Thromb Haemost 1984;51:50-53.
24. Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol 1984;13: 160-7.
25. Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JRA. Platelet aggregation in whole blood determined using the Ultra-Flo 100 platelet counter. Thromb Haemost 1982;48:327-9.
26. Born GVR. Platelets. In: Biggs R, ed. Human blood coagulation haemostasis and thrombosis. Oxford: Blackwell, 1976:180.
27. Harbury CB, Hershgold JE, Schrier SL. Requirements for aggregation of washed human platelets suspended in buffered salt solutions. Thrombosis et Diathesis Haemorrhagica 1972;28:2-13.
28. Tollefsen DM, Majerus PW. Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments. J Clin Invest 1975;55:1259-68.
29. Stone MC, Thorp JM. Plasma fibrinogen-a major coronary risk factor. In: Lenzi S, Descovich GC, eds. Atherosclerosis and Czrdiovascular Diseases. Bologna: Editrice Compositori, 1984:3-10.
30. Wilhelmsen L, Svardsudd K, Kosran-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
31. Lowe GDO, Reavey MM, Johnston RV, Forbes CD, Prentice CRM. Increased platelet aggregates in vascular and non-vascular illness: Correlation with plasma fibrinogen and effect of ancrod. Thromb Res 1979;14:377-86.
32. Carvalho ACA, Coleman RW, Lees RS. Platelet function in hyperbetalipoproteinaemia. N Engl J Med 1974;290:434-8.
33. Lowe GDO, Drummond MM, Third et al JLHC Increased plasma fibrinogen and IHD-aggregates in type II hyperlipoproteinaemia. Thromb Haemost 1980;42:1503-7.
34. Lowe GDO. Laboratory evaluation of hypercoagulability. Clin Haematol 1981; 8:417-20.
35. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, haemodynamic, Theological and biochemical findings in 126 patients with intermittent claudication. Br Med J 1973;4:576-81.
36. Meade TW, Vickers MV, Thompson SG, Seghatchian J. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res (in press).